---
title: "Foyou Pharma: Dydrogesterone Tablets Obtained Drug Registration Certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262000486.md"
description: "According to the Zhitong Finance APP, Foyou Pharma announced that its wholly-owned subsidiary Zhejiang Aisheng Pharmaceutical Co., Ltd. (referred to as \"Zhejiang Aisheng\") has received the Drug Registration Certificate for Dydrogesterone Tablets (Specification: 10mg) issued by the National Medical Products Administration, approving the production of this drug. Dydrogesterone is an orally absorbable synthetic progestogen"
datetime: "2025-10-21T08:08:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262000486.md)
  - [en](https://longbridge.com/en/news/262000486.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262000486.md)
---

# Foyou Pharma: Dydrogesterone Tablets Obtained Drug Registration Certificate

According to the Zhitong Finance APP, Foyou Pharma (601089.SH) announced that its wholly-owned subsidiary Zhejiang Aisheng Pharmaceutical Co., Ltd. (referred to as "Zhejiang Aisheng") has received the Drug Registration Certificate for Dydrogesterone Tablets (Specification: 10mg) issued by the National Medical Products Administration, approving the production of this drug. Dydrogesterone is an orally absorbable synthetic progestogen

### Related Stocks

- [601089.CN](https://longbridge.com/en/quote/601089.CN.md)

## Related News & Research

- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [Chemtrade Logistics Holds Guidance Amid Commodity Swings](https://longbridge.com/en/news/286831060.md)
- [PRECIOUS-Gold falls more than 2% as Treasury yields, dollar weigh amid inflation concerns](https://longbridge.com/en/news/286943432.md)
- [PRECIOUS-Treasury yields, dollar weigh on gold amid inflation concerns](https://longbridge.com/en/news/286929968.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)